Related Experiment Video
Updated: Apr 21, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets
Muzamil Ahmad, Nawab J Dar, Zubair S Bhat
1Neuropharmacology Laboratory, Indian Institute of Integrative Medicine-CSIR, Sanat Nagar, Srinagar, 190005, India. mahmad@iiim.res.in.
None:
Ischemic stroke is caused when blood flow to the brain is hampered, leading to instant deficiency of nutrients and oxygen required for normal brain functioning. Reperfusion can alleviate damage from stroke if performed immediately after the onset of ischemia however the efficacy of reperfusion is tempered by secondary injury mechanisms. This multifarious sequence of events leads to the commencement of deleterious cycles of inflammation, oxidant stress and apoptosis that finally culminate in delayed death of neuronal cells even when the brain is effectively reperfused. Wealth of data from clinical as well as experimental studies points to a prominent role of inflammation in secondary injury. In this review we will discuss, in detail, the cellular and molecular mediators of inflammation and their possible therapeutic targets in both experimental and clinical forms of stroke.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Inflammation II: Local and Systemic Effects

